NYSEMKT:CANF
Can-Fite BioPharma Ltd Stock News
$2.09
+0.0600 (+2.96%)
At Close: May 03, 2024
Can Fite Files Patent for Namodenoson to Overcome Drug Resistance to Checkpoint Inhibitors for Oncology Indications
12:00am, Monday, 24'th Feb 202080 Biggest Movers From Yesterday
09:44am, Tuesday, 11'th Feb 2020
Gainers
Taubman Centers, Inc. (NYSE: TCO) shares jumped 53.2% to close at $53.12 on Monday. Simon Property Group, Inc. (NYSE: SPG) said Monday it plans to purchase an 80%...
Can-Fite BioPharma Prices ~3.33M Unit Offering At $1.50/Unit
12:00am, Monday, 10'th Feb 2020Can-Fite Completes 50% Patient Enrollment In Phase III Rheumatoid Arthritis Study & Implements Interim Analysis
12:00am, Monday, 03'rd Feb 2020Mid-Afternoon Market Update: Crude Oil Down 2%; NeuroMetrix Shares Plummet
07:15pm, Monday, 27'th Jan 2020
Toward the end of trading Monday, the Dow traded down 1.2% to 28,642.56 while the NASDAQ fell 1.56% to 9,169.34. The S&P also fell, dropping 1.26% to 3,254.06.
Leading and...
ACB, MS among premarket gainers
02:14pm, Thursday, 16'th Jan 2020
Neon Therapeutics (NASDAQ:NTGN) +62% on being acquired by BioNTech.Cemtrex (NASDAQ:CETX) +61%.Signet Jewelers (NYSE:SIG) +32% after strong guidance.Reebonz Holding (NASDAQ:RBZ) +15%.XPO Logistics (
